DSM, the Dutch multinational nutrition technology company, announced on April 19th that it has entered into exclusive negotiations with Adare Pharma Solutions, a pharmaceutical company based in the United States, to acquire the biotechnology company Adare Biome for €275 million. This transaction implies an estimated enterprise value-to-EBITDA multiple of 18 for the year 2023.
Postbiotics, also known as “postbiotics” or “paraprobiotics”, refer to the beneficial microbial components derived from processed probiotics, including bacterial cells and their metabolite …
